Piramal Pharma Share Price: The company’s revenue from operations increased to Rs 2,242 crore in the second quarter, up 17% year-on-year from Rs 1,911 crore in the same period last year, mainly due to strong growth in its CDMO business.
| Subscribe To Our Free Newsletter |
